Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duk-In Jon

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
International Clinical Psychopharmacology|July 23, 2013
Aripiprazole augmentation for treatment of patients with chronic or recurrent major depressive disorder: a 12-week prospective open-label multicentre studyChi-Un Pae, Hong Jin Jeon, Boung Chul Lee, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|January 26, 2023
Korean Medication Algorithm Project for Bipolar Disorder 2022: Comparisons with Other Treatment GuidelinesJong-Hyun Jeong, Won-Myong Bahk, Young Sup Woo, et al.
Psychiatry and Clinical Neurosciences|November 10, 2009
Risperidone in the treatment of mixed state bipolar patients: results from a 24-week, multicenter, open-label study in KoreaYoung Sup Woo, Won-Myong Bahk, Duk-In Jon, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|October 20, 2022
Korean Medication Algorithm Project for Bipolar Disorder 2022, Fifth Revision: An Executive SummaryYoung Sup Woo, Won-Myong Bahk, Jong-Hyun Jeong, et al.
International Journal of Methods in Psychiatric Research|February 21, 2019
The prevalence and diagnostic classification of mixed features in patients with major depressive episodes: A multicenter study based on the DSM-5In Hee Shim, Jonghun Lee, Moon-Doo Kim, et al.
Clinical Neuropharmacology|July 28, 2010
Efficacy and tolerability of Blonanserin in the patients with schizophrenia: a randomized, double-blind, risperidone-compared trialJaewon Yang, Won-Myong Bahk, Hyun-Sang Cho, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 23, 2009
Rash in adult patients receiving lamotrigine to treat bipolar I disorder in Korea: a multicenter, prospective, naturalistic, open-label trialYoung Sup Woo, Won-Myong Bahk, Duk-In Jon, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|October 25, 2021
Korean Medication Algorithm for Depressive Disorder 2021, Fourth Revision: An Executive SummaryJeong Seok Seo, Won-Myong Bahk, Young Sup Woo, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|January 26, 2022
The Korean Medication Algorithm Project for Depressive Disorder 2021: Comparisons with Other Treatment GuidelinesYoung Sup Woo, Won-Myong Bahk, Jeong Seok Seo, et al.
Journal of Affective Disorders|February 1, 2024
Preventive effect of aripiprazole once-monthly on relapse into mood episodes in bipolar disorder: A multicenter, one-year, retrospective, mirror image studyYoung Sup Woo, Jong-Hyun Jeong, Hangoeunbi Kang, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
International Clinical Psychopharmacology|July 23, 2013
Aripiprazole augmentation for treatment of patients with chronic or recurrent major depressive disorder: a 12-week prospective open-label multicentre studyChi-Un Pae, Hong Jin Jeon, Boung Chul Lee, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|January 26, 2023
Korean Medication Algorithm Project for Bipolar Disorder 2022: Comparisons with Other Treatment GuidelinesJong-Hyun Jeong, Won-Myong Bahk, Young Sup Woo, et al.
Psychiatry and Clinical Neurosciences|November 10, 2009
Risperidone in the treatment of mixed state bipolar patients: results from a 24-week, multicenter, open-label study in KoreaYoung Sup Woo, Won-Myong Bahk, Duk-In Jon, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|October 20, 2022
Korean Medication Algorithm Project for Bipolar Disorder 2022, Fifth Revision: An Executive SummaryYoung Sup Woo, Won-Myong Bahk, Jong-Hyun Jeong, et al.
International Journal of Methods in Psychiatric Research|February 21, 2019
The prevalence and diagnostic classification of mixed features in patients with major depressive episodes: A multicenter study based on the DSM-5In Hee Shim, Jonghun Lee, Moon-Doo Kim, et al.
Clinical Neuropharmacology|July 28, 2010
Efficacy and tolerability of Blonanserin in the patients with schizophrenia: a randomized, double-blind, risperidone-compared trialJaewon Yang, Won-Myong Bahk, Hyun-Sang Cho, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 23, 2009
Rash in adult patients receiving lamotrigine to treat bipolar I disorder in Korea: a multicenter, prospective, naturalistic, open-label trialYoung Sup Woo, Won-Myong Bahk, Duk-In Jon, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|October 25, 2021
Korean Medication Algorithm for Depressive Disorder 2021, Fourth Revision: An Executive SummaryJeong Seok Seo, Won-Myong Bahk, Young Sup Woo, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|January 26, 2022
The Korean Medication Algorithm Project for Depressive Disorder 2021: Comparisons with Other Treatment GuidelinesYoung Sup Woo, Won-Myong Bahk, Jeong Seok Seo, et al.
Journal of Affective Disorders|February 1, 2024
Preventive effect of aripiprazole once-monthly on relapse into mood episodes in bipolar disorder: A multicenter, one-year, retrospective, mirror image studyYoung Sup Woo, Jong-Hyun Jeong, Hangoeunbi Kang, et al.
Pageof 8